You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR TORSEMIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TORSEMIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00334386 ↗	Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.	Completed	Ferrer Internacional S.A.	Phase 4	2005-04-01	Primary objective:To demonstrate the no-inferiority in efficacy of treatment with Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension. Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.
NCT00602303 ↗	Bioequivalency Study of Torsemide Tablets Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2003-09-01	The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00602615 ↗	Bioequivalency Study of Torsemide Tablets Under Fed Conditions	Completed	Roxane Laboratories	N/A	2003-09-01	The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.
NCT00653549 ↗	Bioavailability Study of Torsemide Tablets Under Fasting Conditions	Completed	Anapharm	Phase 1	2001-04-01	To compare the single-dose bioavailability of Torsemide tablets with Demadex
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TORSEMIDE

Condition Name

Chart
Table

Condition Name for TORSEMIDE
Intervention	Trials
Heart Failure	6
Acute Decompensated Heart Failure	2
Hypertension	2
Congestive Heart Failure	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TORSEMIDE
Intervention	Trials
Heart Failure	10
Hypertension	4
Malnutrition	2
Pulmonary Arterial Hypertension	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TORSEMIDE

Trials by Country

Map
Table

Trials by Country for TORSEMIDE
Location	Trials
United States	37
India	3
Germany	2
Brazil	1
Egypt	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TORSEMIDE
Location	Trials
Texas	3
Missouri	3
New York	2
North Carolina	2
Ohio	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TORSEMIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TORSEMIDE
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	2
Phase 2	2
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TORSEMIDE
Clinical Trial Phase	Trials
Completed	13
Recruiting	6
Terminated	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TORSEMIDE

Sponsor Name

Chart
Table

Sponsor Name for TORSEMIDE
Sponsor	Trials
Sarfez Pharmaceuticals, Inc.	4
Yale University	2
Roxane Laboratories	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TORSEMIDE
Sponsor	Trials
Industry	15
Other	15
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.